VOLITIONRX LTD — Investor Relations & Filings
Filings indexed
1,115
across all filing types
Latest filing
2026-05-22
Regulatory Filings
Country
US
United States of America
Listing
US
VNRX
VolitionRx Ltd. is an epigenetics company that develops blood tests for the early diagnosis and monitoring of life-altering diseases in both humans and animals. The company's core technology is its proprietary Nu.Q® platform, which is based on the science of Nucleosomics. This platform detects and quantifies characteristic changes in circulating nucleosomes, which are fragments of chromatin released from cells. These nucleosomes act as biomarkers for various conditions, enabling the development of simple, cost-effective, and non-invasive tests. VolitionRx's primary focus is on applications for detecting and monitoring cancers and sepsis, with the goal of improving patient outcomes by making diagnostics more accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-22 | English | |
| FORM 8-K | 2026-05-15 | English | |
| FORM 10-Q | 2026-05-14 | English | |
| FORM 8-K | 2026-05-14 | English | |
| PRE 14A | 2026-05-13 | English | |
| 10-K/A - VOLITIONRX LTD (0000093314) (Filer) | 2026-04-30 | English |
Browse filings by year
27 years- 2026 55 filings
- 2025 141 filings
- 2024 137 filings
- 2023 91 filings
- 2022 99 filings
- 2021 69 filings
- 2020 62 filings
- 2019 53 filings
- 2018 54 filings
- 2017 38 filings
- 2016 69 filings
- 2015 54 filings
- 2014 35 filings
- 2013 18 filings
- 2012 34 filings
- 2011 21 filings
- 2010 4 filings
- 2009 3 filings
- 2008 5 filings
- 2007 5 filings
- 2006 10 filings
- 2005 16 filings
- 2004 14 filings
- 2003 12 filings
- 2002 12 filings
- 2001 2 filings
- 2000 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46860821 | FORM 8-K | 2026-05-22 | English | ||
| 46362602 | FORM 8-K | 2026-05-15 | English | ||
| 46282526 | FORM 10-Q | 2026-05-14 | English | ||
| 46289268 | FORM 8-K | 2026-05-14 | English | ||
| 45996034 | PRE 14A | 2026-05-13 | English | ||
| 39221610 | 10-K/A - VOLITIONRX LTD (0000093314) (Filer) | 2026-04-30 | English | ||
| 38179404 | 8-K - VOLITIONRX LTD (0000093314) (Filer) | 2026-04-28 | English | ||
| 35725804 | 8-K - VOLITIONRX LTD (0000093314) (Filer) | 2026-04-23 | English | ||
| 34662690 | 8-K - VOLITIONRX LTD (0000093314) (Filer) | 2026-04-17 | English | ||
| 45996052 | FORM 8-K | 2026-04-01 | English | ||
| 33122056 | 10-K - VOLITIONRX LTD (0000093314) (Filer) | 2026-03-31 | English | ||
| 33122037 | 8-K - VOLITIONRX LTD (0000093314) (Filer) | 2026-03-31 | English | ||
| 32878517 | 4 - VOLITIONRX LTD (0000093314) (Filer) | 2026-03-03 | English | ||
| 32878518 | 4 - VOLITIONRX LTD (0000093314) (Filer) | 2026-03-03 | English | ||
| 32878519 | 4 - VOLITIONRX LTD (0000093314) (Filer) | 2026-03-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
EXICURE, INC.
Early-stage biotech developing nucleic acid therapies based…
|
XCUR | US | Professional, scientific and te… |
|
EyeGene,Inc
Develops gene/cell therapies for age-related diseases and p…
|
185490 | KR | Professional, scientific and te… |
|
Femtobiomed Inc.
Develops a non-viral intracellular delivery platform for ce…
|
327610 | KR | Professional, scientific and te… |
|
Fermi Inc.
Develops AI data center campuses with co-located hybrid pow…
|
FRMI | US | Professional, scientific and te… |
|
Fluicell AB
A biotech firm creating engineered tissues for regenerative…
|
FLUI | SE | Professional, scientific and te… |
|
Flydoo Technology Holding Limited
Provides comprehensive travel services, package tours, and …
|
8069 | HK | Professional, scientific and te… |
|
Foghorn Therapeutics Inc.
Develops medicines targeting the chromatin regulatory syste…
|
FHTX | US | Professional, scientific and te… |
|
Fortrea Holdings Inc.
A global CRO providing clinical development and patient acc…
|
FTRE | US | Professional, scientific and te… |
|
Foxtron
Specializes in electric vehicle design, open platforms, and…
|
2258 | TW | Professional, scientific and te… |
|
FRMSP
Develops ophthalmology and oncology therapies using proprie…
|
6838 | TW | Professional, scientific and te… |
VOLITIONRX LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34395/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34395 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34395 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34395 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34395}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for VOLITIONRX LTD (id: 34395)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.